UPDATED Apr 16, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A211050 | ₩4,900.00 | 9.1% | 135.6% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
A439090 | ₩18,670.00 | -0.8% | n/a | ₩305.8b | n/a | PE26.3x | E49.6% | n/a | Household | ||
A178320 | ₩24,450.00 | 2.9% | 29.9% | ₩907.4b | ₩31,000.00 | PS1.2x | E89.6% | 0.6% | Tech | ||
CALTX | kr101.00 | -12.6% | -20.3% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$146.72 | -5.9% | -27.2% | US$18.7b | US$220.22 | PS10.1x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.77 | 0.8% | -22.3% | US$200.3m | US$19.00 | PS7.3x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$9.70 | -35.2% | -35.2% | US$244.1m | US$26.90 | PS5x | E64.5% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.08 | -16.4% | 45.7% | US$225.0m | US$8.50 | PS2.6x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$14.00 | -7.3% | -33.9% | US$2.0b | US$29.75 | PE160x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | kr3.43 | -1.7% | -40.9% | kr83.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
688711 | CN¥25.76 | -6.4% | -66.9% | CN¥3.7b | CN¥97.00 | PE34.1x | E50.0% | 0.05% | Semiconductors | ||
CAI | AU$0.12 | -11.1% | -54.7% | AU$95.1m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
HHR | AU$0.008 | 14.3% | -78.9% | AU$22.5m | n/a | PE7.6x | E86.3% | n/a | Energy | ||
AXSM | US$68.21 | -3.9% | -5.5% | US$3.3b | US$121.13 | PS11.9x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
SEAPT | kr5.14 | -1.9% | -60.5% | kr1.8b | kr11.57 | PB1x | E54.2% | n/a | Energy | ||
CLBIO | kr11.55 | -6.9% | 15.5% | kr248.2m | kr32.00 | PS7x | E71.1% | n/a | Pharmaceuticals & Biotech | ||
300820 | CN¥45.68 | -0.7% | -48.0% | CN¥9.6b | CN¥70.67 | PE24.4x | E33.5% | 0.7% | Capital Goods | ||
FTCI | US$0.45 | -11.9% | -82.8% | US$50.9m | n/a | PB0.9x | E63.1% | n/a | Capital Goods | ||
688390 | CN¥103.49 | -3.9% | -49.3% | CN¥17.4b | CN¥133.61 | PE20.6x | E27.1% | 1.1% | Capital Goods | ||
300389 | CN¥14.46 | -0.6% | -15.2% | CN¥5.0b | n/a | PE16.3x | E35.7% | 2.1% | Tech | ||
300442 | CN¥30.72 | 17.7% | -20.9% | CN¥49.3b | CN¥32.19 | PE35.3x | E35.1% | 2.5% | Software | ||
SONM | US$0.50 | -17.6% | -59.5% | US$22.0m | US$2.00 | PB1x | E139.9% | n/a | Tech | ||
1830 | HK$2.51 | -20.8% | -36.3% | HK$3.2b | HK$5.89 | PE9.5x | E32.5% | 10.6% | Consumer Services | ||
ADR | AU$0.031 | -22.5% | -31.1% | AU$10.7m | n/a | PS4.4x | E110.1% | n/a | Healthcare |